SciSparc Ltd. (NASDAQ:SPRC) Short Interest Update

SciSparc Ltd. (NASDAQ:SPRC) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 69,800 shares, an increase of 336.3% from the May 31st total of 16,000 shares. Based on an average daily trading volume, of 361,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.9% of the company’s stock are sold short.

SciSparc Stock Down 2.5 %

NASDAQ SPRC traded down $0.02 during trading on Friday, reaching $0.83. 72,972 shares of the company’s stock were exchanged, compared to its average volume of 727,693. SciSparc has a 1 year low of $0.80 and a 1 year high of $15.86. The company has a 50 day moving average price of $1.10 and a two-hundred day moving average price of $2.72.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.